Biotech investors in London, United Kingdom
Updated 16 Nov 2026
Venture funds
7 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Dementia Discovery Fund Dementia Discovery Fund invests exclusively in novel dementia therapeutics, with recent investments in Alchemab Therapeutics and Cerevance. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 42% | 2 |
| 2 | Exceptional Ventures Exceptional Ventures focuses on early-stage entrepreneurs and businesses that improve people's lives, and recently backed Sava Technology and Amatera. London, United Kingdom |
Health care, Biotech | Seed, Early stage venture | 8% | 2 |
| 3 | Future Planet Capital London, United Kingdom |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 3% | 2 |
| 4 | Medicxi Medicxi focuses on life sciences, with recent companies Vaderis Therapeutics and D3 Bio. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 54% | 2 |
| 5 | Octopus Ventures Octopus Ventures supports companies from idea conception to IPO, including Living Optics and Edgify. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 54% | 2 |
| 6 | SoftBank Vision Fund SoftBank Vision Fund makes growth capital and social impact investments, with recent companies including WHOOP and Opentrons. London, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 71% | 2 |
| 7 | XTX Ventures XTX Ventures invests in startups applying machine learning, recently backing CloudNC and Qureight. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture | 22% | 2 |
Table 1. Biotech investors in London, United Kingdom: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Octopus Ventures | Venture capital firm | London, United Kingdom | •••@octopusvnetures.com | +44 20••• |
| Future Planet Capital | Venture capital firm | London, United Kingdom | •••@futureplanetcapital.com | +44 79••• |
| Marshall Wace | Hedge fund | London, United Kingdom | •••@mwam.com | 212 23••• |
| Medicxi | Venture capital firm | London, United Kingdom | •••@medicxi.com | +44 20••• |
| IP Group | Venture capital firm | London, United Kingdom | •••@ipgroupplc.com | +44 (0••• |
| Parkwalk Advisors | Venture capital firm | London, United Kingdom | •••@parkwalkadvisors.com | +44 20••• |
| Janus Henderson Investors | Private equity firm | London, United Kingdom | •••@janushenderson.com | +44 (0••• |
| Abingworth | Private equity firm | London, United Kingdom | •••@abingworth.com | (207) ••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 27 of the 40 biotech investors in London, United Kingdom have a published email address, 26 a phone number and 40 a website.
- Octopus Ventures has the most recorded investments, 477, 259 of them as lead investor.
- 30 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Seedcamp is an investor in 15 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Takenos' $7.0M seed round on 4 November 2026.
- Software is the most common sector across their 1,426 portfolio companies (78%).
- Early stage venture is the most common investment stage, recorded for 37 of them (92%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in London, United Kingdom
30 of 40, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Octopus Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Living Optics, Metris Energy, Edgify | 9 | 477 | 259 | 73 | •••@octopusvnetures.com | +44 20••• | In the CSV |
| 2 | Future Planet Capital | Venture capital firm | London, United Kingdom | Biotech, Health care | Luffy AI, Captura, CellCentric | 4 | 360 | 12 | 27 | •••@futureplanetcapital.com | +44 79••• | In the CSV |
| 3 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | Fintech, Health care | Kaiko, Sonosemi Medical, Exponent Energy | 8 | 552 | 236 | 134 | +91 80••• | In the CSV | |
| 4 | SoftBank Vision Fund | Private equity firm, Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Opentrons, WHOOP, Early Health | 4 | 471 | 334 | 91 | +44 02••• | In the CSV | |
| 5 | Marshall Wace | Hedge fund | London, United Kingdom | Biotech, Health care | TRM Labs | 1 | 80 | 18 | 38 | •••@mwam.com | 212 23••• | In the CSV |
| 6 | Medicxi | Venture capital firm | London, United Kingdom | Biotech, Health care | Vaderis Therapeutics, D3 Bio | 2 | 59 | 32 | 16 | •••@medicxi.com | +44 20••• | In the CSV |
| 7 | IP Group | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | Microbiotica, Oxford Quantum Circuits, Oxa | 3 | 304 | 59 | 38 | •••@ipgroupplc.com | +44 (0••• | In the CSV |
| 8 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | Hardware, Artificial intelligence | OSSTEC, Adsilico, Reclinker | 10 | 339 | 91 | 32 | •••@parkwalkadvisors.com | +44 20••• | In the CSV |
| 9 | Janus Henderson Investors | Private equity firm, Venture capital firm | London, United Kingdom | Health care, Biotech | Claris Biotherapeutics | 1 | 240 | 34 | 144 | •••@janushenderson.com | +44 (0••• | In the CSV |
| 10 | Abingworth | Private equity firm, Venture capital firm | London, United Kingdom | Biotech, Health care | Timberlyne Therapeutics, Myricx Bio, Anjarium Biosciences | 196 | 56 | 90 | •••@abingworth.com | (207) ••• | In the CSV | |
| 11 | IQ Capital | Venture capital firm | London, United Kingdom | Artificial intelligence, Cybersecurity | Mindgard, Quantum Diamonds, RevEng | 4 | 183 | 60 | 20 | •••@iqcapital.vc | +44 (0••• | In the CSV |
| 12 | RebelBio | Startup accelerator | London, United Kingdom | Biotech, Health care | VisusNano, Rize Health, Helixworks | 120 | 0 | 2 | In the CSV | |||
| 13 | Kindred Capital | Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Fractile, Dexory, Infinitopes | 3 | 108 | 33 | 12 | •••@kindredcapital.vc | +44 75••• | In the CSV |
| 14 | MVM Life Science Partners | Venture capital firm | London, United Kingdom | Health care, Biotech | GT Medical Technologies, SkyCell, Xention | 76 | 34 | 28 | •••@mvm.com | +44 (0••• | In the CSV | |
| 15 | Creator Fund | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Malted AI, Quantum Diamonds, Helical | 6 | 68 | 27 | 3 | •••@thecreatorfund.com | In the CSV | |
| 16 | Balderton Capital | Venture capital firm | London, United Kingdom | Fintech, Artificial intelligence | Sava Technology, TILT, Primer | 7 | 477 | 216 | 98 | •••@balderton.com | +44 (0••• | In the CSV |
| 17 | 3i Group | Private equity firm, Venture capital firm | London, United Kingdom | Hardware, Health care | Twenga, Endosense, OmniGuide | 476 | 140 | 195 | •••@3i.com | 44 (0)••• | In the CSV | |
| 18 | Tiny Supercomputer Investment Company | Venture capital firm | London, United Kingdom | Artificial intelligence, Hardware | Zero, Neuphonic, bunch | 8 | 174 | 2 | 21 | In the CSV | ||
| 19 | Dementia Discovery Fund | Venture capital firm | London, United Kingdom | Biotech, Health care | Alchemab Therapeutics, Cerevance | 2 | 50 | 21 | 3 | •••@svhealthinvestors.com | In the CSV | |
| 20 | Seedcamp | Micro VC fund, Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Metaview, Flow Engineering, Rayon | 15 | 688 | 101 | 83 | •••@seedcamp.com | +44 20••• | In the CSV |
| 21 | Startupbootcamp | Startup accelerator | London, United Kingdom | Fintech, Artificial intelligence | Brickken | 1 | 620 | 58 | 56 | •••@startupbootcamp.org | In the CSV | |
| 22 | Business Growth Fund | Private equity firm, Venture capital firm | London, United Kingdom | Commerce, Hardware | Open Cosmos | 1 | 492 | 408 | 106 | •••@businessgrowthfund.co.uk | +03452••• | In the CSV |
| 23 | Outlier Ventures | Startup accelerator | London, United Kingdom | Fintech, Artificial intelligence | Takenos, Kaisar Network, Drex | 3 | 358 | 63 | 9 | •••@outlierventures.io | +44 75••• | In the CSV |
| 24 | Northzone | Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Rayon, Tandem Health, Monumental | 6 | 347 | 148 | 60 | +46 85••• | In the CSV | |
| 25 | Wellcome Trust | Government investment office, Venture capital firm | London, United Kingdom | Health care, Hardware | ThinkSono, Antabio, Acesion Pharma | 133 | 52 | 42 | •••@wellcome.ac.uk | +44 20••• | In the CSV | |
| 26 | 24 Haymarket | Private equity firm, Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Previsico, Mogrify, Kelda Showers | 103 | 42 | 12 | •••@24haymarket.com | +44 20••• | In the CSV | |
| 27 | Talis Capital | Venture capital firm | London, United Kingdom | Artificial intelligence, Fintech | Seqera, Monomer Bio, Kimai | 80 | 43 | 20 | •••@taliscapital.com | +44 (0••• | In the CSV | |
| 28 | XTX Ventures | Corporate venture arm | London, United Kingdom | Artificial intelligence, Health care | CloudNC, Qureight, Lucida Medical | 4 | 76 | 17 | 9 | •••@xtxmarkets.com | In the CSV | |
| 29 | Ada Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Education | Boldr, Noggin HQ, Firenze | 4 | 73 | 25 | 1 | In the CSV | ||
| 30 | Advent Life Sciences | Venture capital firm | London, United Kingdom | Biotech, Health care | Beacon Therapeutics | 1 | 69 | 24 | 16 | •••@adventls.com | (440) ••• | In the CSV |
Table 2. Biotech investors in London, United Kingdom: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 40.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Seedcamp | London, United Kingdom | 15 | 203 | Metaview, Flow Engineering, Rayon |
| 2 | Parkwalk Advisors | London, United Kingdom | 10 | 38 | OSSTEC, Adsilico, Reclinker |
| 3 | Octopus Ventures | London, United Kingdom | 9 | 122 | Living Optics, Metris Energy, Edgify |
| 4 | Tiny Supercomputer Investment Company | London, United Kingdom | 8 | 64 | Zero, Neuphonic, bunch |
| 5 | Eight Roads Ventures | London, United Kingdom | 8 | 106 | Kaiko, Sonosemi Medical, Exponent Energy |
| 6 | Balderton Capital | London, United Kingdom | 7 | 80 | Sava Technology, TILT, Primer |
| 7 | Northzone | London, United Kingdom | 6 | 60 | Rayon, Tandem Health, Monumental |
| 8 | Creator Fund | London, United Kingdom | 6 | 17 | Malted AI, Quantum Diamonds, Helical |
| 9 | SoftBank Vision Fund | London, United Kingdom | 4 | 71 | Opentrons, WHOOP, Early Health |
| 10 | XTX Ventures | London, United Kingdom | 4 | 24 | CloudNC, Qureight, Lucida Medical |
| 11 | Ada Ventures | London, United Kingdom | 4 | 24 | Boldr, Noggin HQ, Firenze |
| 12 | IQ Capital | London, United Kingdom | 4 | 34 | Mindgard, Quantum Diamonds, RevEng |
| 13 | Future Planet Capital | London, United Kingdom | 4 | 31 | Luffy AI, Captura, CellCentric |
| 14 | UCL Technology Fund | London, United Kingdom | 4 | 10 | Gaussion, Gigaton, Stanhope AI |
| 15 | Outlier Ventures | London, United Kingdom | 3 | 185 | Takenos, Kaisar Network, Drex |
Table 3. Biotech investors in London, United Kingdom: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Takenos | Takenos offers a digital wallet that lets users receive, send, manage, and spend international money. | Fintech | Buenos Aires, Argentina | Seed | $7.0M | 2026-11-04 | $12.2M | Outlier Ventures | 11 to 50 | 2022 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | Parkwalk Advisors | 11 to 50 | 2021 |
| Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Kindred Capital | 101 to 250 | 2022 |
| Opentrons Unicorn | Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. | Artificial intelligence | Long Island City, United States | Series E | $40.0M | 2026-10-29 | $300.2M | SoftBank Vision Fund | 251 to 500 | 2014 |
| Onego Bio | Onego Bio produces egg protein through fermentation as a food ingredient. | Biotech | Helsinki, Finland | Series B | $28.0M | 2026-10-26 | $100.6M | NordicNinja VC | 11 to 50 | 2022 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds, United Kingdom | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors | 1 to 10 | 2022 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | IP Group | 11 to 50 | 2016 |
| Danu Robotics | Danu Robotics provides artificial intelligence and robotic solutions for recycling and waste management. | Artificial intelligence | Edinburgh, United Kingdom | Seed | $5.0M | 2026-10-10 | $5.1M | Sustainable Ventures | 1 to 10 | 2020 |
| Sava Technology | Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. | Biotech | London, United Kingdom | Series B | $36.0M | 2026-10-09 | $62.8M | Balderton Capital, Exceptional Ventures | 101 to 250 | 2016 |
| Metaview | Metaview provides an AI recruiting platform that automates and supports hiring workflows. | Artificial intelligence | San Francisco, United States | Series C | $60.0M | 2026-09-30 | $109.6M | Seedcamp | 101 to 250 | 2018 |
Table 4. Biotech investors in London, United Kingdom: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 1,116 | 78% |
| Fintech | 372 | 26% |
| Artificial intelligence | 347 | 24% |
| Hardware | 209 | 15% |
| Health care | 197 | 14% |
| Commerce | 135 | 9% |
| Biotech | 122 | 9% |
| Cybersecurity | 59 | 4% |
| Education | 57 | 4% |
| Energy | 28 | 2% |
Table 5. Biotech investors in London, United Kingdom: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 37 | 92% |
| Seed investors | 34 | 85% |
| Venture investors | 22 | 55% |
| Late stage investors | 18 | 45% |
| Private equity investors | 8 | 20% |
| Debt investors | 5 | 12% |
| Convertible note investors | 4 | 10% |
| Post IPO investors | 4 | 10% |
Table 6. Biotech investors in London, United Kingdom by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 5 | 12% |
| 2010s | 18 | 45% |
| 2000s | 9 | 22% |
| 1990s | 4 | 10% |
| 1970s | 1 | 2% |
| 1960s | 1 | 2% |
Table 7. Biotech investors in London, United Kingdom by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in London, United Kingdom. On 16 November 2026 that is 40 investors.
- 27 rows carry an email address and 26 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 40 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in London, United Kingdom are on the list?
- 40, in the file dated 16 November 2026. 30 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 27 of the 40 carry an email address in the download and 26 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 40 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 40 rows, 27 firm email addresses and 26 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 22 of the 27 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.